MicroRNA-623 Inhibits Epithelial–Mesenchymal Transition to Attenuate Glioma Proliferation by Targeting TRIM44

Dawei Cui,Kaijie Wang,Yan Liu,Junling Gao,Jianzhong Cui
DOI: https://doi.org/10.2147/ott.s250497
IF: 4
2020-09-01
OncoTargets and Therapy
Abstract:OBJECTIVE: Glioma has the highest incidence among the different tumor types within the nervous system, accounting for about 40% of them. Malignant glioma has a high invasion and metastasis rate, which leads to the poor prognosis of patients. By targeting specific genes, microRNAs serve as key regulators in the epithelial-mesenchymal transformation (EMT) process, which could provide new insights into the treatment of glioblastomas (GBM). The detailed molecular role that miR-623 plays in GBM still remains unclear.MATERIALS AND METHODS: The level of miR-623 in GBM cells was evaluated by RT-PCR. The function of miR-623 overexpression on GBM cell proliferation, migration, and invasion was assessed by MTS, Transwell analysis, and colony formation assay. In addition, a mouse subcutaneous xenograft model was used to study in vivo effects. The binding between miR-623 and <i>TRIM44</i> was verified by a dual-luciferase reporter assay and the regulatory function of miR-623 on EMT markers was evaluated using Western blot.RESULTS: The expression of miR-623 was repressed in the GBM cancer cell lines. MiR-623 overexpression or <i>TRIM44</i> knockdown attenuated the proliferation, migration, and invasion of GBM cell lines. <i>TRIM44</i> could facilitate the reverse suppression of EMT and miR-623 in GBM progression. MiR-623 was found to inhibit <i>TRIM44</i> expression by directly binding to its 3'UTR. In addition, systemic delivery of miR-623 mimic reduced tumor growth and inhibited <i>TRIM44</i> protein expression in tumor-bearing nude mice. Furthermore, our findings indicated that miR-623 overexpression or <i>TRIM44</i> down-regulation impeded the proliferation and migratory ability of LN229 and U251MG glioma cells, and miR-623 attenuates <i>TRIM44</i>-induced EMT by directly targeting the 3'UTR of <i>TRIM44</i>, which could serve as preliminary research to identify potential therapeutic targets for future treatment of GBM.CONCLUSION: Overall, microRNA-623 inhibits epithelial-mesenchymal transition to attenuate glioma proliferation by targeting <i>TRIM44.</i>
oncology,biotechnology & applied microbiology
What problem does this paper attempt to address?